Dmitri Krysko
Prof. Dr. Dmitri Krysko is the head of the Cell Death Investigation and Therapy (CDIT) Laboratory at the Ghent University and an elected member of The Royal Academy of Medicine of Belgium. He earned his MD in 1998 from the Medical State University of Saratov, Russia, and PhD in 2006 from the Ghent University, Belgium.
The CDIT laboratory primarily focuses on understanding the role of different regulated cell death modalities in cancer and developing new experimental cell-based cancer immunotherapies. The team achieved a groundbreaking discovery in ferroptosis immunogenicity and the development of novel glioma immunotherapy, which is based on a dendritic cell vaccine and immunogenic cell death induced by photodynamic therapy. Prof. Krysko’s contributions have been recognized with several awards including the GSK Vaccine 2019 Immunology Award and the AstraZeneca Foundation 2019 Oncology Award which highlight his exceptional achievements in the field of cancer immunotherapy.
Abstracts this author is presenting: